Open AccessMother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in Botswana
Author(s) -
Sonya Davey,
Gbolahan Ajibola,
Kenneth Maswabi,
Maureen Sakoi,
Kara Bennett,
Michael D. Hughes,
Arielle Isaacson,
Modiegi Diseko,
Rebecca Zash,
Oganne Batlang,
Sikhulile Moyo,
Shahin Lockman,
Mathias Lichterfeld,
Daniel R. Kuritzkes,
Joseph Makhema,
Roger Shapiro
Publication year - 2020
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002338
Subject(s) - dolutegravir , efavirenz , regimen , emtricitabine , medicine , pregnancy , in utero , pediatrics , obstetrics , confidence interval , abacavir , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load , virology , fetus , biology , genetics
A large-scale evaluation of mother-to-child transmission (MTCT) with dolutegravir (DTG)-based antiretroviral treatment (ART) has not been conducted previously.